Measles immunity and response to revaccination among secondary school children in Cumbria

Epidemiology and Infection

Volumn 116, Issue 1, 1996, Pages 65-70

  Calvert, N ^a   Cutts, F ^b   Irving, R ^a   Brown, D ^c   Marsh, J ^a   Miller, E ^d  

^a North Cumbria Health Authority   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d Serv Communic Dis Survlnc Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; NEUTRALIZING ANTIBODY;

ADOLESCENT; ARTICLE; HIGH SCHOOL; HUMAN; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; MEASLES; REVACCINATION; SALIVA ANALYSIS; SCHOOL CHILD; UNITED KINGDOM;

EID: 0029968766     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268800058969     Document Type: Article

References (22)

1. Carter H, Gorman D. Measles, mumps and rubella vaccine: time for a two stage policy? BMJ 1992; 304: 637.
2. Lyons RA, Jones HI, Salmos RL. Successful control of a school based measles outbreak by immunization. Epidemiol Infect 1994; 113: 367-75.
3. Hill A. Measles, mumps and rubella vaccination. BMJ 1992; 304: 779.
4. Morse D, O'Shea M, Hamilton G, et al. Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents. Epidemiol Infect 1994; 113: 355-65.
5. Ramsay M, Gay N, Miller E, et al. The epidemiology of measles in England and Wales. CDR Rev 1994; 4: R141-6.
6. Babad HR, Nokes DJ, Gay NJ, Miller E. Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect 1995; 114: 319-44.
7. Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995; 115: 139-56.
8. Calvert N, Cutts F, Miller E, Brown DWG, Munro J. Measles among secondary school children in West Cumbria: implications for vaccination policy. CDR 1994; 4: 70-3.
9. Brown DWG, Miller E. Facing the measles epidemic. Practitioner 1994, 238: 778-81.
10. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990; 162: 1036-42.
11. Perry K, Brown DWG, Parry JV, et al. Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassays. J Med Virol 1993; 40: 235-40.
12. Albrecht P, Herrman K, Burns GR, Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3: 251-60.
13. Sinitsyna OA, Khudaverdyan OE, Steinberg LL, et al. Further attenuated measles vaccine: virus passages affect virus surface protein expression, immunogenicity and histopathology pattern in vivo. Res Virol 1990; 141: 517-31.
14. Forsey T, Heath AB, Minor PD, The 1st international standard for anti-measles serum. Biologicals 1991; 19: 237-41.
15. Samb B, Aaby P, Whittle HC, et al. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995; 14: 203-9.
16. Pedersen IR, Mordhurst CH, Glickmann G, von Magnus H. Subclinical measles infection in vaccinated seropositive individuals in Greenland. Vaccine 1989; 7: 345-8.
17. Markowitz LE, Albrecht PA, Orenstein WA, Lett SM, Pugliese TJ. Farrell D. Persistence of measles antibody after revaccination. J Infect Dis 1992; 166: 205-8.
18. Christenson B, Bottiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres, and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994; 12: 129-33.
19. Cohn ML, Robinson ED, Faerber M, et al. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults, Pediatr Infect Dis J 1994; 13: 34-8.
20. Cutts FT, Bartoloni A, Guglielmetti P, Gil F, Brown D. Bianchi Bandinelli ML, Roselli M. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. Trans R Soc Trop Med Hyg 1995: 89: 119-22.
21. Thieme T, Piacentin S, Davidson S, Steingart K. Determination of measles, mumps and rubella immunization status using oral fluid samples. JAMA 1994; 272: 219-21.
22. Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ 1994; 308: 1015-7.